Watch the session live!

The Influenza B/Yamagata lineage appears to become extinct: implications for quadrivalent influenza vaccines?

Wednesday 20 September 2023, 17:15 - 17:30 CEST

Chair:

Ab Osterhaus
BIO
Ab Osterhaus
ESWI Chair, TiHO, Germany

Ben Cowling, University of Hong Kong, Hong Kong S.A.R. 

Wenqing Zhang, World Health Organization, Switzerland

ESWI activities

ESWI Airborne: Burden of Disease
ESWI has launched a new podcast series addressing the burden of disease of acute respiratory virus infections.
RSV Symposium 2023
19 September 2023
Valencia & online
9th Influenza Conference 2023
17 - 20 September 2023
Valencia
ESWI webinar series 2021
How can countries cope with more than one major respiratory virus spreading, while non- pharmaceutical interventions are being loosened week by week?

Agenda

2023
9-13
September
ERS International Congress 2023
Milan, Italy
ERS annual event will bring together the world’s respiratory experts to showcase all the latest advances in respiratory medicine and science.
2023
17-20
September
ESWI EVENT
9th Influenza Conference 2023
Valencia
2023
19
September
ESWI EVENT
RSV Symposium 2023
Valencia & online
2023
20-22
September
19th EuGMS Congress
Helsinki
The European Geriatric Medicine Society (EUGMS) is hosting in Helsinki a conference addressing healthy ageing in the changing world.
2023
12
October
MENA-ISN Influenza Day 2023
Online
Unmet needs for influenza vaccination
2023
15-17
October
World Health Summit 2023
Berlin
The World Health Summit stands for a science-driven and broad approach to global health development

Education hub

News
TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry
SARS-CoV-2 is associated with broad tissue tropism, a characteristic often determined by the availability of entry receptors on host cells.
News
Dispersal patterns and influence of air travel during the global expansion of SARS-CoV-2 variants of concern
News
Long Covid: clues about causes
This investigated the monocyte and inflammatory profiles of individuals who were hospitalised with COVID-19 during the acute phase and the convalescent period.
News
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
This study demonstrates durable yet compartmentalised nasal IgA and plasma antibody responses to SARSCoV-2 after infection and subsequent vaccination.

ESWI networks & communities

Influenza Diabetes Community

The Influenza Diabetes Community (IDC) unites scientists, healthcare professionals, patient -and other stakeholder organisations to discuss, share best practices and to network with the objective to raise awareness of the burden of influenza, Covid-19 and RSV in people living with diabetes.

Young Scientists Network

Some of the best and most innovative ideas come from young scientists, and young scientists are the future of the influenza field. For this reason, ESWI has been actively encouraging the careers of young scientists for many years.